scyllo-Inositol (SI) is a stereoisomer of inositol whose catabolism has not been characterized in bacteria. We found that Bacillus subtilis 168 was able to grow using SI as its sole carbon source and that this growth was dependent on a functional iol operon for catabolism of myo-inositol (MI; another inositol isomer, which is abundant in nature). Previous studies elucidated the MI catabolic pathway in B. subtilis as comprising multiple stepwise reactions catalysed by a series of Iol enzymes. The first step of the pathway converts MI to scyllo-inosose (SIS) and involves the MI dehydrogenase IolG. Since IolG does not act on SI, we suspected that there could be another enzyme converting SI into SIS, namely an SI dehydrogenase. Within the whole genome, seven genes paralogous to iolG have been identified and two of these, iolX and iolW (formerly known as yisS and yvaA, respectively), were selected as candidate genes for the putative SI dehydrogenase since they were both prominently expressed when B. subtilis was grown on medium containing SI. iolX and iolW were cloned in Escherichia coli and both were shown to encode a functional enzyme, revealing the two distinct SI dehydrogenases in B. subtilis. Since inactivation of iolX impaired growth with SI as the carbon source, IolX was identified as a catabolic enzyme required for SI catabolism and it was shown to be NAD+ dependent. The physiological role of IolW remains unclear, but it may be capable of producing SI from SIS with NADPH oxidation.
GalbraithM. P.,
FengS. F.,
BornemanJ.,
TriplettE. W.,
de BruijnF. J.,
RossbachS.1998; A functional myo-inositol catabolism pathway is essential for rhizopine utilization by Sinorhizobium meliloti. Microbiology 144:2915–2924
HippsP. P.,
EvelandM. R.,
LairdM. H.,
ShermanW. R.1976; The identification of myo-inositol : NAD(P)+ oxidoreductase in mammalian brain. Biochem Biophys Res Commun 68:1133–1138
IchimuraK.,
KohataK.,
YamaguchiY.,
DouzonoM.,
IkedaH.,
KoketsuM.2000; Identification of l-inositol and scyllitol and their distribution in various organs in chrysanthemum. Biosci Biotechnol Biochem 64:865–868
InaokaT.,
TakahashiK.,
YadaH.,
YoshidaM.,
OchiK.2004; RNA polymerase mutation activates the production of a dormant antibiotic 3,3′-neotrehalosadiamine via an autoinduction mechanism in Bacillus subtilis. J Biol Chem 279:3885–3892
JiangG.,
KrishnanA. H.,
KimY. M.,
WacekT. J.,
KrishnanH. B.2001; A functional myo-inositol dehydrogenase gene is required for efficient nitrogen fixation and competitiveness of Sinorhizobium fredii USDA191 to nodulate soybean ( Glycine max [L.] Merr.). J Bacteriol 183:2595–2604
KaempferR. O.,
MagasanikB.1967; Effect of infection with T-even phage on the inducible synthesis of beta-galactosidase in Escherichia coli. J Mol Biol 27:453–468
KringsE.,
KrumbachK.,
BatheB.,
KelleR.,
WendischV. F.,
SahmH.,
EggelingL.2006; Characterization of myo-inositol utilization by Corynebacterium glutamicum: the stimulon, identification of transporters, and influence on l-lysine formation. J Bacteriol 188:8054–8061
OguraM.,
YamaguchiH.,
YoshidaK.,
FujitaY.,
TanakaT.2001; DNA microarray analysis of Bacillus subtilis DegU, ComA and PhoP regulons: an approach to comprehensive analysis of B. subtilis two-component regulatory systems. Nucleic Acids Res 29:3804–3813
RiggsB. M.,
LansleyT. A.,
RyalsP. E.2007; Phosphatidylinositol synthase of Tetrahymena: inositol isomers as substrates in phosphatidylinositol biosynthesis and headgroup exchange reactions. J Eukaryot Microbiol 54:119–124
RosenbergN. K.,
LeeR. W.,
YanceyP. H.2006; High contents of hypotaurine and thiotaurine in hydrothermal-vent gastropods without thiotrophic endosymbionts. J Exp Zool A Comp Exp Biol 305:655–662
SambrookJ.,
RussellD. W.2001Molecular Cloning: a Laboratory Manual, 3rd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
ShermanW. R.,
StewartM. A.,
SimpsonP. C.,
GoodwinS. L.1968; The identification of myo-inosose-2 and scyllo-inositol in mammalian tissues. Biochemistry 7:819–824
SunY.,
ZhangG.,
HawkesC. A.,
ShawJ. E.,
McLaurinJ.,
NitzM.2008; Synthesis of scyllo-inositol derivatives and their effects on amyloid beta peptide aggregation. Bioorg Med Chem 16:7177–7184
TownsendM.,
ClearyJ. P.,
MehtaT.,
HofmeisterJ.,
LesneS.,
O'HareE.,
WalshD. M.,
SelkoeD. J.2006; Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers. Ann Neurol 60:668–676
YebraM. J.,
ZunigaM.,
BeaufilsS.,
Perez-MartinezG.,
DeutscherJ.,
MonederoV.2007; Identification of a gene cluster enabling Lactobacillus casei BL23 to utilize myo-inositol. Appl Environ Microbiol 73:3850–3858
YoshidaK. I.,
AoyamaD.,
IshioI.,
ShibayamaT.,
FujitaY.1997; Organization and transcription of the myo-inositol operon, iol, of Bacillus subtilis. J Bacteriol 179:4591–4598
YoshidaK. I.,
ShibayamaT.,
AoyamaD.,
FujitaY.1999a; Interaction of a repressor and its binding sites for regulation of the Bacillus subtilis iol divergon. J Mol Biol 285:917–929
YoshidaK.,
YamaguchiM.,
MorinagaT.,
IkeuchiM.,
KineharaM.,
AshidaH.2006; Genetic modification of Bacillus subtilis for production of d- chiro-inositol, an investigational drug candidate for treatment of type 2 diabetes and polycystic ovary syndrome. Appl Environ Microbiol 72:1310–1315